RSHO Cancer Patient Treatment

Medical Marijuana, Inc. Receives COFEPRIS Permission for RSHO-X™ Usage for Cancer Patient

Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being   SAN DIEGO, CA – January 24, 2017 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™…

HempMeds® Announces Groundbreaking Distribution Partnership with Paragon HealthCare

Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR   Partnership to Provide Expanded Accessibility to RSHO™, the First-Ever Product Approved for Import by Brazilian Government   San Diego, CA – Dec. 19, 2016 – Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United…